Next Generation Dx Summit 2017 | Predicting Responses to Cancer Immunotherapy - a podcast by Cambridge Healthtech Podcasts

Robert Anders of Johns Hopkins Medicine speaks to CHI on May 16th, 2017. Dr. Anders will be speaking during the Biomarkers for Cancer Immunotherapy and Combinations meeting at the Next Generation Diagnostics Summit August 15-18th in Washington DC.

Topics include the integration of genomic, proteomic and immunological markers for cancer immunotherapy, challenges in implementing multiplex approaches, and more.

For more information, please visit http://www.NextGenerationDx.com/Biomarkers-Cancer-Immunotherapy/

Further episodes of CHI Podcasts

Further podcasts by Cambridge Healthtech Podcasts

Website of Cambridge Healthtech Podcasts